Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed and InterMune Start Biomarker Collaboration

NEW YORK, March 4 - SurroMed and InterMune are collaborating to discover new biomarkers, the companies said today.


SurroMed will analyze clinical samples provided by InterMune using its mass spectrometry-based technology.


InterMune hopes new biomarkers will help it better understand drug responses in ongoing clinical trials as well as find new drugs for pulmonary and hepatic disease.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.